Deloitte December 12, 2017
My Take
Whenever I get to the final page of my wall calendar, I always feel compelled to reflect on the past 12 months. There were quite a few bright spots for health care stakeholders in 2017. Innovations in delivery and payment system reforms appear to be working. New therapies are curing diseases. Competition is expanding in the life sciences space. And after years of volatility, the individual health insurance market is showing some signs of stability.
I contacted the leaders of Deloitte’s Life Sciences and Health Care practice, as well as our research and policy teams, and asked them to highlight some of the bright spots they saw in 2017. We came up with a pretty extensive list.
Delivery...
Today's Sponsors
Today's Sponsor